Song X. Targeting of both PI3K/Akt/mTOR pathway and mutant EGFR to overcome resistance to tyrosine kinase inhibitors in mutant EGFR-mediated lung cancer. OR. 2013;1(1):pp.13-19. doi:10.14259/or.v1i1.81